SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001535610-20-000091
Filing Date
2020-05-01
Accepted
2020-05-01 08:38:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G ATNM 5.01.20 atnm0520.txt SC 13G 11768
  Complete submission text file 0001535610-20-000091.txt   13382
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82467 | Film No.: 20838531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G